Anne Wojcicki

Who is Anne Wojcicki?

Anne brings to 23andMe a 10-year background in

healthcare investing, focused primarily on biotechnology companies.

Anne left the investing world with the hope that she could have a

positive impact on the medical world and the biotechnology industry

through 23andMe. From her vantage point, Anne saw a need for creating a

way to generate more information—especially more personalized

information—so that biotech and pharmaceutical companies could better

understand and develop new drugs and diagnostics. By encouraging

individuals to access and learn about their own genetic information,

23andMe will create a common, standardized resource that has the

potential to accelerate drug discovery and bring personalized medicine

to the public. (Plus, getting access to her own genetic information and

understanding it has always been one of Anne's ambitions.) Anne

graduated from Yale University with a B.S. in biology.